ADMA BIOLOGICS, INC. (ADMA) Gross margin 2016–2025
ADMA BIOLOGICS, INC. (ADMA) gross margin by fiscal year — reported gross profit divided by reported revenue.
57.4%FY2025 · since FY2016: 40.3% → 57.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 57.4% | +5.9 pp |
| FY2024 | 51.5% | +17.0 pp |
| FY2023 | 34.4% | +11.6 pp |
| FY2022 | 22.9% | +21.4 pp |
| FY2021 | 1.4% | +46.6 pp |
| FY2020 | -45.2% | — |
| FY2018 | -148.4% | -120.3 pp |
| FY2017 | -28.1% | -68.5 pp |
| FY2016 | 40.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice